Products for Research Use Only
RegisterLogin

JAK-IN-40

CAT: 0804-HY-170927Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-170927Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JAK-IN-40 (Compound 46) is the inhibitor for JAK that inhibits JAK1, JAK2 and JAK3 with IC50s of 0.022, 0.759 and 1.601 μM, respectively. JAK-IN-40 inhibits the phosphorylation of STAT3. JAK-IN-40 inhibits the proliferation of cancer cell Ba/F3 and JAK1-TEL Ba/F3 with GI50 of 0.614 μM and 0.193 μM. JAK-IN-40 arrests cell cycle of H1975 and H2087 at G2/M phase, induces apoptosis. JAK-IN-40 exhibits a synergistic antitumor effect with Osimertinib.
UNSPSC
12352005
Target
Apoptosis; JAK; STAT
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(NC1=CC=CC(C2=CSC3=CN=C(NC4=CN(C)N=C4OC)N=C32)=C1)[C@@H](C)N5CCN(CCO)CC5
Molecular Formula
C26H32N8O3S
Molecular Weight
536.65
References & Citations
[1]Kim Y, et al., Identification of Thieno[3,2-d]pyrimidine derivatives as potent and selective Janus Kinase 1 inhibitors. Eur J Med Chem. 2025 Mar 15;286:117308.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-151262-01JAK-IN-23
HY-157011JAK-IN-33
HY-111471JAK-IN-5
HY-18301-01JAK-IN-35
HY-111749JAK-IN-4
HY-144057JAK-IN-17
HY-143444-01JAK-IN-20
HY-14986JAK-IN-32
HY-46262JAK-IN-15
HY-153440-01JAK-IN-25

Alternative Products

CatalogName
GTR19249604-01JAK-IN-40
BA4919-10JAK-IN-14
BA4937-1JAK-IN-30
BA4922-1JAK-IN-24
JDC67353-01JAK-IN-1
T210131-01JAK-IN-37
T12549-01JAK-IN-11
T79222-01JAK-IN-29
T73250-01JAK-IN-17
MBS3844679-01JAK-IN-4

Popular Products